Core Scientific Shareholders Rejected $9B Sale Before AMD Deal
Core Scientific investors turned down a $9B buyout. A new AMD partnership now raises questions about whether they made the right call.
Core Scientific shareholders made a bold bet when they voted down a $9 billion acquisition offer, and a newly announced partnership with semiconductor giant AMD is now prompting serious debate about whether that rejection was the right move. The deal, which would have handed investors an immediate and substantial payout, was passed over in favor of an independent future — one that appears to be taking shape in dramatic fashion.
The AMD partnership signals a meaningful pivot for Core Scientific, a bitcoin mining and high-performance computing infrastructure company that emerged from bankruptcy in early 2024. Aligning with one of the world's leading chip designers suggests the company is positioning itself at the intersection of AI infrastructure and digital assets — a space attracting enormous capital and attention from major technology players.
Read more Berkshire Ends 14-Quarter Selling Streak With $23.5B Stock Spree →
For shareholders who rejected the buyout, the AMD news may feel like validation. A $9 billion exit, while substantial, could look modest if Core Scientific successfully captures a slice of the surging demand for AI compute infrastructure. Investors who held out are now watching to see whether management can convert a high-profile chip partnership into durable revenue and long-term shareholder value.
Still, the outcome is far from certain. Partnerships with large technology companies do not always translate into the financial windfalls that early optimism suggests, and Core Scientific must now execute against a competitive landscape that includes well-capitalized rivals. The pressure on leadership to deliver results — and justify shareholders' confidence in walking away from a near-term premium — has never been higher.
Continue reading at Yahoo Finance.
